Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacek Gronwald

Showing results (131-140 of 307) with videos related to

Pageof 31
Sort By:
Cancer Causes & Control : CCC|May 12, 2012
Plasma micronutrients, trace elements, and breast cancer in BRCA1 mutation carriers: an exploratory studyJoanne Kotsopoulos, Grzegorz Sukiennicki, Magdalena Muszyńska, et al.
Journal of Medical Genetics|July 29, 2009
Survival in women with MMR mutations and ovarian cancer: a multicentre study in Lynch syndrome kindredsEli Marie Grindedal, Laura Renkonen-Sinisalo, Hans Vasen, et al.
Breast Cancer Research and Treatment|February 7, 2018
Physical activity during adolescence and young adulthood and the risk of breast cancer in BRCA1 and BRCA2 mutation carriersJacqueline Lammert, Jan Lubinski, Jacek Gronwald, et al.
Cancers|August 23, 2020
Prevalence of Recurrent Mutations Predisposing to Breast Cancer in Early-Onset Breast Cancer Patients from PolandEmilia Rogoża-Janiszewska, Karolina Malińska, Cezary Cybulski, et al.
Cancers|August 10, 2024
Cobalt Serum Level as a Biomarker of Cause-Specific Survival among Prostate Cancer PatientsSandra Pietrzak, Wojciech Marciniak, Róża Derkacz, et al.
British Journal of Cancer|May 2, 2025
Parity, breastfeeding, and the risk of early-onset breast cancer in women with a BRCA1 pathogenic variantJoanne Kotsopoulos, Christopher A Maxwell, Jan Lubinski, et al.
International Journal of Cancer|December 7, 2005
Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an updateJacek Gronwald, Nadine Tung, William D Foulkes, et al.
Cancers|July 20, 2021
Blood Arsenic Levels as a Marker of Breast Cancer Risk among <i>BRCA1</i> CarriersWojciech Marciniak, Tomáš Matoušek, Susan Domchek, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 16, 2008
Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study GroupKelly A Metcalfe, Jan Lubinski, Parviz Ghadirian, et al.
Journal of the National Cancer Institute|September 25, 2008
Hormone therapy and the risk of breast cancer in BRCA1 mutation carriersAndrea Eisen, Jan Lubinski, Jacek Gronwald, et al.
Pageof 31

Showing results (131-140 of 307) with videos related to

Sort By:
Pageof 31
Cancer Causes & Control : CCC|May 12, 2012
Plasma micronutrients, trace elements, and breast cancer in BRCA1 mutation carriers: an exploratory studyJoanne Kotsopoulos, Grzegorz Sukiennicki, Magdalena Muszyńska, et al.
Journal of Medical Genetics|July 29, 2009
Survival in women with MMR mutations and ovarian cancer: a multicentre study in Lynch syndrome kindredsEli Marie Grindedal, Laura Renkonen-Sinisalo, Hans Vasen, et al.
Breast Cancer Research and Treatment|February 7, 2018
Physical activity during adolescence and young adulthood and the risk of breast cancer in BRCA1 and BRCA2 mutation carriersJacqueline Lammert, Jan Lubinski, Jacek Gronwald, et al.
Cancers|August 23, 2020
Prevalence of Recurrent Mutations Predisposing to Breast Cancer in Early-Onset Breast Cancer Patients from PolandEmilia Rogoża-Janiszewska, Karolina Malińska, Cezary Cybulski, et al.
Cancers|August 10, 2024
Cobalt Serum Level as a Biomarker of Cause-Specific Survival among Prostate Cancer PatientsSandra Pietrzak, Wojciech Marciniak, Róża Derkacz, et al.
British Journal of Cancer|May 2, 2025
Parity, breastfeeding, and the risk of early-onset breast cancer in women with a BRCA1 pathogenic variantJoanne Kotsopoulos, Christopher A Maxwell, Jan Lubinski, et al.
International Journal of Cancer|December 7, 2005
Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an updateJacek Gronwald, Nadine Tung, William D Foulkes, et al.
Cancers|July 20, 2021
Blood Arsenic Levels as a Marker of Breast Cancer Risk among <i>BRCA1</i> CarriersWojciech Marciniak, Tomáš Matoušek, Susan Domchek, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 16, 2008
Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study GroupKelly A Metcalfe, Jan Lubinski, Parviz Ghadirian, et al.
Journal of the National Cancer Institute|September 25, 2008
Hormone therapy and the risk of breast cancer in BRCA1 mutation carriersAndrea Eisen, Jan Lubinski, Jacek Gronwald, et al.
Pageof 31